Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (130) 130
child (92) 92
male (84) 84
female (82) 82
pediatrics (79) 79
oncology (75) 75
child, preschool (72) 72
index medicus (67) 67
children (60) 60
infant (59) 59
adolescent (55) 55
chemotherapy (36) 36
clinical neurology (30) 30
treatment outcome (28) 28
tumors (28) 28
hepatoblastoma (26) 26
antineoplastic combined chemotherapy protocols - therapeutic use (25) 25
cancer (23) 23
adult (21) 21
liver cancer (21) 21
surgery (21) 21
combined modality therapy (20) 20
care and treatment (19) 19
childhood (19) 19
cisplatin (19) 19
liver neoplasms - pathology (19) 19
research (19) 19
infant, newborn (18) 18
liver neoplasms - drug therapy (17) 17
follow-up studies (15) 15
hematology (15) 15
prospective studies (15) 15
hepatoblastoma - drug therapy (14) 14
liver neoplasms - surgery (14) 14
magnetic resonance imaging (14) 14
medicine & public health (14) 14
doxorubicin - administration & dosage (13) 13
hepatoblastoma - pathology (13) 13
liver (13) 13
prognosis (13) 13
risk factors (13) 13
brain neoplasms - pathology (12) 12
cisplatin - administration & dosage (12) 12
diagnosis (12) 12
brain neoplasms - drug therapy (11) 11
doxorubicin (11) 11
health aspects (11) 11
hepatoblastoma - surgery (11) 11
liver neoplasms - therapy (11) 11
brain neoplasms - therapy (10) 10
hepatoblastoma - therapy (10) 10
international-society (10) 10
radiotherapy (10) 10
childhood hepatoblastoma (9) 9
international society (9) 9
italy (9) 9
neurosciences (9) 9
pediatric-oncology-group (9) 9
prognostic-factors (9) 9
retrospective studies (9) 9
risk (9) 9
survival analysis (9) 9
time factors (9) 9
antineoplastic combined chemotherapy protocols - adverse effects (8) 8
brain neoplasms - diagnosis (8) 8
hematology, oncology and palliative medicine (8) 8
infusion doxorubicin (8) 8
italy - epidemiology (8) 8
patients (8) 8
tumors in children (8) 8
age (7) 7
analysis (7) 7
brain neoplasms - radiotherapy (7) 7
brain tumors (7) 7
carboplatin - administration & dosage (7) 7
chemotherapy, adjuvant (7) 7
children's hospitals (7) 7
clinical trials (7) 7
disease (7) 7
disease-free survival (7) 7
glioma - pathology (7) 7
gliomas (7) 7
liver neoplasms - mortality (7) 7
liver transplantation (7) 7
low-grade glioma (7) 7
lung neoplasms - secondary (7) 7
medulloblastoma (7) 7
meningeal neoplasms - pathology (7) 7
survival (7) 7
therapy (7) 7
transplantation (7) 7
abridged index medicus (6) 6
astrocytoma (6) 6
carboplatin (6) 6
drug therapy (6) 6
hospitals (6) 6
liver tumors (6) 6
management (6) 6
medical colleges (6) 6
medicine (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Commentary on: “The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma.” By Burzynski et al
by Perilongo, Giorgio
Child's Nervous System, ISSN 0256-7040, 12/2014, Volume 30, Issue 12, pp. 2071 - 2072
A potential effective therapy for diffuse intrinsic pontine glioma (DIPG) is far to be developed. There are no “shortcuts” to reach this goal. Only a rigid,... 
Neurosciences | Chemotherapy | Medicine & Public Health | Diffuse intrinsic glioma | Alternative medicine | Neurosurgery | Radiotherapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Giulio J. D'Angio, MD, 1922–2018
by Maris, John M and Perilongo, Giorgio
Pediatric Blood & Cancer, ISSN 1545-5009, 01/2019, Volume 66, Issue 1, pp. e27508 - n/a
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration
by Meyers, Rebecka L, Prof and Maibach, Rudolf, PhD and Hiyama, Eiso, Prof and Häberle, Beate, MD and Krailo, Mark, PhD and Rangaswami, Arun, Prof and Aronson, Daniel C, MD and Malogolowkin, Marcio H, Prof and Perilongo, Giorgio, Prof and von Schweinitz, Dietrich, Prof and Ansari, Marc, Prof and Lopez-Terrada, Dolores, Prof and Tanaka, Yukichi, MD and Alaggio, Rita, Prof and Leuschner, Ivo, Prof and Hishiki, Tomoro, MD and Schmid, Irene, MD and Watanabe, Kenichiro, MD and Yoshimura, Kenichi, PhD and Feng, Yurong, MSe and Rinaldi, Eugenia and Saraceno, Davide and Derosa, Marisa and Czauderna, Piotr, Prof
Lancet Oncology, The, ISSN 1470-2045, 2017, Volume 18, Issue 1, pp. 122 - 131
Summary Background Comparative assessment of treatment results in paediatric hepatoblastoma trials has been hampered by small patient numbers and the use of... 
Hematology, Oncology and Palliative Medicine | SYSTEM | ONCOLOGY | PRETREATMENT PROGNOSTIC-FACTORS | DOXORUBICIN | DISEASE | EXTENT | VALIDATION | SURGICAL RESECTION | LIVER-TUMOR | SOCIETY | Prognosis | Prospective Studies | Follow-Up Studies | Humans | Child, Preschool | Infant | Male | Liver Neoplasms - therapy | Neoplasm Staging - standards | Hepatoblastoma - secondary | Female | Liver Neoplasms - pathology | Child | Infant, Newborn | Databases, Factual | alpha-Fetoproteins - metabolism | Hepatoblastoma - therapy | Japan | Risk Factors | Cooperative Behavior | Survival Rate | Combined Modality Therapy | Lymphatic Metastasis | International Agencies | Adolescent | Pediatrics | Medical colleges | Liver cancer | International cooperation | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Brain and spinal tumors of childhood
by Walker, David A., 1953
2004, ISBN 0340762608, xx, 531 p. , [8] p. of plates
Brain | Tumors in children | Spine | Tumors
Book
Details down arrow
5. Full Text Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study
by Zsiros, József, Dr and Brugieres, Laurence, MD and Brock, Penelope, MD and Roebuck, Derek, MD and Maibach, Rudolf, PhD and Zimmermann, Arthur, MD and Childs, Margaret and Pariente, Daniele, MD and Laithier, Veronique, MD and Otte, Jean-Bernard, Prof and Branchereau, Sophie, MD and Aronson, Daniel, MD and Rangaswami, Arun, MD and Ronghe, Milind, MD and Casanova, Michela, MD and Sullivan, Michael, MD and Morland, Bruce, MD and Czauderna, Piotr, MD and Perilongo, Giorgio, Prof and Int Childhood Liver Tumours and International Childhood Liver Tumours Strategy Group (SIOPEL)
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 9, pp. 834 - 842
Summary Background The objective of this study was to establish the efficacy and safety of a new treatment regimen consisting of dose-dense cisplatin-based... 
Hematology, Oncology and Palliative Medicine | BREAST-CANCER | INFUSION DOXORUBICIN | ONCOLOGY | METASTATIC HEPATOBLASTOMA | MODERN-ERA | CHILDHOOD HEPATOBLASTOMA | INTERNATIONAL SOCIETY | PEDIATRIC-ONCOLOGY-GROUP | PHASE-II | COMBINATION | LIVER-TUMOR | Prognosis | Prospective Studies | Follow-Up Studies | Lung Neoplasms - mortality | Humans | Child, Preschool | Male | Liver Neoplasms - therapy | Liver Neoplasms - mortality | Cisplatin - administration & dosage | Feasibility Studies | Hepatectomy | Dose-Response Relationship, Drug | Lung Neoplasms - secondary | Female | Liver Neoplasms - pathology | Child | Doxorubicin - administration & dosage | Hepatoblastoma - pathology | Hepatoblastoma - therapy | Survival Rate | Combined Modality Therapy | Lung Neoplasms - therapy | Hepatoblastoma - mortality | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Antimitotic agents | Medical colleges | Liver cancer | Chemotherapy | Children's hospitals | Antineoplastic agents | Cancer | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Commentary on: "The response and survival of children with recurrent diffuse intrinsic pontine glioma based on phase II study of antineoplastons A10 and AS2-1 in patients with brainstem glioma." By Burzynski et al
by Perilongo, G
CHILDS NERVOUS SYSTEM, ISSN 0256-7040, 12/2014, Volume 30, Issue 12, pp. 2071 - 2072
A potential effective therapy for diffuse intrinsic pontine glioma (DIPG) is far to be developed. There are no "shortcuts" to reach this goal. Only a rigid,... 
SURGERY | Chemotherapy | Diffuse intrinsic glioma | Alternative medicine | CLINICAL-TRIALS | PEDIATRICS | SUBGROUPS | Radiotherapy | CLINICAL NEUROLOGY | Pons | Benzeneacetamides - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Humans | Neoplasm Recurrence, Local - drug therapy | Female | Male | Phenylacetates - therapeutic use | Glutamine - analogs & derivatives | Piperidones - therapeutic use | Brain Stem Neoplasms - drug therapy | Glioma - drug therapy | Antimitotic agents | Care and treatment | Usage | Gliomas | Patient outcomes | Diagnosis | Antineoplastic agents | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Giulio (Dan) J. D’Angio, MD (1922–2018)
by Maris, John M and Perilongo, Giorgio and Markowitz, Richard I
Pediatric Radiology, ISSN 0301-0449, 5/2019, Volume 49, Issue 6, pp. 837 - 838
Pediatrics | Medicine & Public Health | Oncology | Nuclear Medicine | Imaging / Radiology | Ultrasound | Neuroradiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Considerations on the Role of Chemotherapy and Modern Radiotherapy in the Treatment of Childhood Low Grade Glioma
by Perilongo, Giorgio
Journal of Neuro-Oncology, ISSN 0167-594X, 12/2005, Volume 75, Issue 3, pp. 301 - 307
The treatment of childhood low grade glioma (LGG), if not amenable to complete resection, quite often is a relevant clinical challenge. LGG in many instances... 
hypothalamic glioma | Medicine & Public Health | pilocytic astrocytoma | radiotherapy | Oncology | chemotherapy | optic glioma | low grade glioma | Optic glioma | Chemotherapy | Low grade glioma | Radiotherapy | Hypothalamic glioma | Pilocytic astrocytoma | GROUP PHASE-II | CLINICAL NEUROLOGY | RADIATION-THERAPY | RECURRENT BRAIN-TUMORS | PILOCYTIC ASTROCYTOMAS | ONCOLOGY | CONFORMAL RADIOTHERAPY | NERVOUS-SYSTEM TUMORS | ORAL ETOPOSIDE | PEDIATRIC-ONCOLOGY-GROUP | OPTIC PATHWAY TUMORS | HYPOTHALAMIC/CHIASMATIC ASTROCYTOMAS | Prognosis | Humans | Brain Neoplasms - pathology | Child, Preschool | Combined Modality Therapy | Brain Neoplasms - drug therapy | Glioma - radiotherapy | Morbidity | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Glioma - pathology | Radiotherapy - methods | Brain Neoplasms - radiotherapy | Health Status | Child | Glioma - drug therapy
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Successful Treatment of Childhood High-Risk Hepatoblastoma With Dose-Intensive Multiagent Chemotherapy and Surgery: Final Results of the SIOPEL-3HR Study
by József Zsíros and Rudolf Maibach and Elizabeth Shafford and Laurence Brugieres and Penelope Brock and Piotr Czauderna and Derek Roebuck and Margaret Childs and Arthur Zimmermann and Veronique Laithier and Jean-Bernard Otte and Beatriz de Camargo and Gordon MacKinlay and Marcelo Scopinaro and Daniel Aronson and Jack Plaschkes and Giorgio Perilongo
Journal of Clinical Oncology, ISSN 0732-183X, 05/2010, Volume 28, Issue 15, pp. 2584 - 2590
Purpose The primary objective was to determine the efficacy of a newly designed preoperative chemotherapy regimen in an attempt to improve the cure rate of... 
INFUSION DOXORUBICIN | ONCOLOGY-GROUP | INTERNATIONAL-SOCIETY | ONCOLOGY | METASTATIC HEPATOBLASTOMA | PRETREATMENT PROGNOSTIC-FACTORS | PEDIATRIC LIVER-TUMOR | MODERN-ERA | EXPERIENCE | CHILDREN | TRANSPLANTATION | Prospective Studies | Humans | Risk Factors | Liver Neoplasms - drug therapy | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Carboplatin - administration & dosage | Child, Preschool | Infant | Liver Neoplasms - surgery | Male | Treatment Outcome | Hepatoblastoma - drug therapy | Preoperative Care | Cisplatin - administration & dosage | Hepatoblastoma - surgery | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Adolescent | Survival Analysis | Female | Chemotherapy, Adjuvant | Child | Doxorubicin - administration & dosage
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Pediatric liver tumors
by Zimmermann, Arthur and Perilongo, Giorgio
2011, Pediatric oncology, ISBN 3642145043
Liver Neoplasms | Child
Web Resource
Details down arrow
11. Full Text Intratracheal administration of clinical-grade mesenchymal stem cell-derived extracellular vesicles reduces lung injury in a rat model of bronchopulmonary dysplasia
by Porzionato, Andrea and Zaramella, Patrizia and Zaramella, Patrizia and Dedja, Arben and Guidolin, Diego and Guidolin, Diego and Van Wemmel, Kelly and Van Wemmel, Kelly and Macchi, Veronica and Jurga, Marcin and Jurga, Marcin and Perilongo, Giorgio and Perilongo, Giorgio and De Caro, Raffaele and Baraldi, Eugenio and Baraldi, Eugenio and Muraca, Maurizio and Muraca, Maurizio
American Journal of Physiology - Lung Cellular and Molecular Physiology, ISSN 1040-0605, 01/2019, Volume 316, Issue 1, pp. L6 - L19
Mesenchymal stem cells (MSCs) prevent the onset of bronchopulmonary dysplasia (BPD) in animal models, an effect that seems to be mediated by their secreted... 
hyperoxia | bronchopulmonary dysplasia | exosomes | THERAPEUTIC APPLICATIONS | PHYSIOLOGY | ASSAY | RESPIRATORY SYSTEM | GROWTH | DISEASE | EXOSOMES | PRETERM INFANTS | UPDATE | STROMAL CELLS | EXPOSURE | DAMAGE | Animal models | Dysplasia | Alveolar air | Mesenchyme | Lung diseases | Medical treatment | Blood vessels | Stem cell transplantation | Exposure | Vascularization | Vesicles | Injury prevention | Animals | Allografts | Rodents | Hyperoxia | Stem cells | Extracellular matrix | Alveoli | Surface area | Trachea
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Corrigendum to “A European randomised controlled trial of the addition of etoposide to standard vincristine and carboplatin induction as part of an 18-month treatment programme for childhood (≤16 years) low grade glioma – A final report” [Eur J of Canc (2017) 206–225]
by Gnekow, Astrid K and Walker, David and Walker, David A and Kandels, Daniela and Picton, Susan and Picton, Sue and Giorgio Perilongo and Grill, Jacques and Stokland, Tore and Sandstrom, Per Erik and Sandstrom, Per Eric and Warmuth-Metz, Monika and Pietsch, Torsten and Giangaspero, Felice and Schmidt, René and Faldum, Andreas and Kilmartin, Denise and De Paoli, Angela and De Salvo, Gian Luca and Slavc, Irene and Perilongo, Giorgio and Clausen, Niels and Arola, Mikko and Jonsson, Olafur Gisli and Cruz, Ofelia and Navajas, Aurora and Teijeiro, Anna and Kalifa, Chantal and Raquin, Marie-Anne and Verlooy, Joris and Hans, Volkmar and Scheurlen, Wolfram and Hainfellner, Johannes and Ironside, James and Robson, Keith and Skullerud, Kari and Scheie, David and NN and Ruchoux, Marie-Madeleine and Jouvet, Anne and Figarella-Branger, Dominique and Lellouch-Toubiana, Arielle and Prayer, Daniela and Calderone, Milena and Jaspan, Tim and Bakke, Soren Jacob and Vazquez, Eli and Couanet, Dominique and Kortmann, Rolf D and Diekmann, Karin and Scarzello, Giovanni and Taylor, Roger and Lote, Knut and Giralt, Jordi and Carrie, Christian and Habrand, Jean Louis and Soerensen, Niels and Czech, Thomas and Chumas, Paul and Gustavson, Bengt and Zerah, Michel and Wabbels, Bettina and Pinello, Maria Luisa and Fielder, Alistair and Simmons, Ian and Christoffersen, Terje and Calaminus, Gabriele and Brockmann, Knut and Straeter, Ronald and Ebinger, Friedrich and Hernaiz-Driever, Pablo and Lackner, Herwig and Kennedy, Colin and Glaser, Adam and Stromberg, Bo and Indiano, Jose Ma and Rodary, Chantal and Bouffet, Eric and Frappaz, Didier and Emser, Angela and Stephens, Suzanne and Machin, David and Le Deley, Marie-Cécile and Egeland, Thore and Freemann, Carolyn and Schrappe, Martin and Sposto, Richard and Medicinska fakulteten and Institutionen för klinisk vetenskap and Pediatrik and Umeå universitet
European Journal of Cancer, ISSN 0959-8049, 02/2018, Volume 90, pp. 156 - 157
The authors regret that the original article did not include an acknowledgement of the Dutch Childhood Oncology Group as part of the International Study... 
Clinical Medicine | Medical and Health Sciences | Cancer and Oncology | Klinisk medicin | Medicin och hälsovetenskap | Cancer och onkologi
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Giulio J. D'Angio, MD, 1922-2018
by Maris, John M and Perilongo, Giorgio
Pediatric blood & cancer, 10/2018, p. e27508
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Cisplatin versus Cisplatin plus Doxorubicin for Standard-Risk Hepatoblastoma
by Perilongo, Giorgio and Maibach, Rudolf and Shafford, Elisabeth and Brugieres, Laurence and Brock, Penelope and Morland, Bruce and de Camargo, Beatriz and Zsiros, Jozsef and Roebuck, Derek and Zimmermann, Arthur and Aronson, Daniel and Childs, Margaret and Widing, Eva and Laithier, Veronique and Plaschkes, Jack and Pritchard, Jon and Scopinaro, Marcello and MacKinlay, Gordon and Czauderna, Piotr
The New England Journal of Medicine, ISSN 0028-4793, 10/2009, Volume 361, Issue 17, pp. 1662 - 1670
In this randomized trial involving children with standard-risk hepatoblastoma, treatment with cisplatin alone caused fewer adverse events and achieved rates of... 
SYSTEM | INFUSION DOXORUBICIN | MEDICINE, GENERAL & INTERNAL | PRETREATMENT PROGNOSTIC-FACTORS | CHILDHOOD HEPATOBLASTOMA | INTERNATIONAL SOCIETY | PEDIATRIC-ONCOLOGY-GROUP | TOXICITY | LIVER-TUMOR | CHEMOTHERAPY | CHILDREN | Humans | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Child, Preschool | Infant | Male | Hepatoblastoma - drug therapy | Antineoplastic Agents - administration & dosage | Liver Neoplasms - mortality | Cisplatin - administration & dosage | Antineoplastic Agents - adverse effects | Female | Chemotherapy, Adjuvant | Child | Doxorubicin - administration & dosage | Liver Neoplasms - drug therapy | Neoplasm Recurrence, Local | Liver Neoplasms - surgery | Hepatoblastoma - mortality | Disease Progression | Hepatoblastoma - surgery | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Biopsy | Survival Analysis | Cisplatin - adverse effects | Doxorubicin - adverse effects | Liver cancer | Care and treatment | Usage | Comparative analysis | Health aspects | Cisplatin | Confidence intervals | Clinical trials | Tomography | Chemotherapy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Sodium Thiosulfate for Protection from Cisplatin-Induced Hearing Loss
by Brock, Penelope R and Maibach, Rudolf and Childs, Margaret and Rajput, Kaukab and Roebuck, Derek and Sullivan, Michael J and Laithier, Véronique and Ronghe, Milind and Dall’Igna, Patrizia and Hiyama, Eiso and Brichard, Bénédicte and Skeen, Jane and Mateos, M. Elena and Capra, Michael and Rangaswami, Arun A and Ansari, Marc and Rechnitzer, Catherine and Veal, Gareth J and Covezzoli, Anna and Brugières, Laurence and Perilongo, Giorgio and Czauderna, Piotr and Morland, Bruce and Neuwelt, Edward A
The New England Journal of Medicine, ISSN 0028-4793, 06/2018, Volume 378, Issue 25, pp. 2376 - 2385
Cisplatin is an effective treatment for hepatoblastoma but often leads to lifelong irreversible hearing loss. The addition of sodium thiosulfate 6 hours after... 
MEDICINE, GENERAL & INTERNAL | CARBOPLATIN | SIOPEL | CHILDRENS-ONCOLOGY-GROUP | INTERNATIONAL-SOCIETY | RISK HEPATOBLASTOMA | BRAIN-BARRIER DISRUPTION | OTOTOXICITY | TOXICITY | DNA ADDUCT FORMATION | CHEMOTHERAPY | Single-Blind Method | Thiosulfates - therapeutic use | Follow-Up Studies | Thiosulfates - adverse effects | Humans | Child, Preschool | Infant | Male | Hepatoblastoma - drug therapy | Liver Neoplasms - mortality | Cisplatin - administration & dosage | Incidence | Female | Drug Therapy, Combination | Child | Hearing Loss - chemically induced | Doxorubicin - administration & dosage | Glomerular Filtration Rate | Liver Neoplasms - drug therapy | Hepatoblastoma - mortality | Adolescent | Survival Analysis | Cisplatin - adverse effects | Thiosulfates - administration & dosage | Hearing Loss - prevention & control | Complications and side effects | Safety and security measures | Dosage and administration | Drug therapy | Sodium thiosulfate | Cisplatin | Risk factors | Hearing loss | Medical research | Liver diseases | Medical imaging | Hearing impairment | α-Fetoprotein | Cancer therapies | Survival | Children & youth | Metastases | Design | Chemotherapy | Sodium | Thiosulfate | Surgery | Children | Deoxyribonucleic acid--DNA | Ototoxicity | Cancer | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Drug discovery in paediatric oncology: Roadblocks to progress
by Adamson, Peter C and Houghton, Peter J and Perilongo, Giorgio and Pritchard-Jones, Kathy
Nature Reviews Clinical Oncology, ISSN 1759-4774, 12/2014, Volume 11, Issue 12, pp. 732 - 739
Approval of new cancer drugs for paediatric patients generally occurs after their development and approval for treating adult cancers. As most drug development... 
EUROPE | DECLINING CHILDHOOD | MODELS | ONCOLOGY | RECURRENT | ADOLESCENTS | RHABDOMYOSARCOMA | ANTIBODY | INNOVATION | CANCER | CHILDREN | Child, Preschool | Drug Discovery - methods | Infant | Child | Humans | Neoplasms - drug therapy | Pediatrics | Oncology | Forecasts and trends | Drug discovery | Methods
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Effects of clinical pathway implementation on antibiotic prescriptions for pediatric community-acquired pneumonia
by Donà, Daniele and Zingarella, Silvia and Gastaldi, Andrea and Lundin, Rebecca and Perilongo, Giorgio and Frigo, Anna Chiara and Hamdy, Rana F and Zaoutis, Theoklis and Dalt, Liviana Da and Giaquinto, Carlo
PLoS ONE, ISSN 1932-6203, 02/2018, Volume 13, Issue 2, p. e0193581
Background Italian pediatric antimicrobial prescription rates are among the highest in Europe. As a first step in an Antimicrobial Stewardship Program, we... 
INFECTIONS | ANTIBACTERIAL DRUG-USE | MANAGEMENT | MULTIDISCIPLINARY SCIENCES | GUIDELINES | RESISTANCE | RISK | KLEBSIELLA-PNEUMONIAE | EPIDEMIOLOGY | SOCIETY | CHILDREN | Drugs | Prescribing | Medical protocols | Antibiotics | Community-acquired infections | Patient outcomes | Dosage and administration | Pneumonia in children | Drug therapy | Standards | Intervention | Therapy | Pediatrics | Pneumonia | Funding | Communities | Physicians | Childrens health | Medical services | Ear diseases | Epidemiology | Antiinfectives and antibacterials | Streptococcus infections | Patient safety | Children | Prescriptions | Supervision | Emergency medical services | Failure | Medical personnel | Mortality | Statistical tests | Children & youth | Infectious diseases | Hospitals | Amoxicillin | Median (statistics) | Viral infections
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
18. Reply to reported missing founding member of the International Society of Paediatric Oncology...found
by Giorgio Perilongo and Giulio D'Angio and Alan Craft and Berta Jereb
Pediatric Blood & Cancer, ISSN 1545-5009, 10/2017, Volume 64, Issue 10
Journal Article
Details down arrow
19. Full Text Atypical adult medulloblastoma: Commentary
by D'Avella, Domenico and Perilongo, Giorgio
Acta Neurochirurgica, ISSN 0001-6268, 07/2011, Volume 153, Issue 7, p. 1517
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
20. Full Text Microscopically positive resection margin after hepatoblastoma resection: what is the impact on prognosis? A Childhood Liver Tumours Strategy Group (SIOPEL) report
by Aronson, Daniel C and Weeda, Víola B and Maibach, Rudolf and Czauderna, Piotr and Dall’Igna, Patrizia and de Ville de Goyet, Jean and Branchereau, Sophie and Perilongo, Giorgio and Brock, Penelope and Zsiros, Joszef and Semeraro, Michaela and Chardot, Christophe and Wildhaber, Barbara and Morland, Bruce and Brugières, Laurence and Childhood Liver Tumour Strategy and Childhood Liver Tumour Strategy Group (SIOPEL)
European Journal of Cancer, ISSN 0959-8049, 01/2019, Volume 106, pp. 126 - 132
To evaluate the impact of a microscopically positive resection margin (microPRM) on the outcome of hepatoblastoma patients pretreated with chemotherapy. Local... 
Children | Partial liver resection | Outcome | Hepatoblastoma | Positive margin | SURGERY | SYSTEM | PRETREATMENT EXTENT | DOXORUBICIN | GUIDELINES | INTERNATIONAL SOCIETY | CISPLATIN | ONCOLOGY | DISEASE | PEDIATRIC HEPATOBLASTOMA | Liver cancer | Chemotherapy | Prognosis | Surgery | Liver |